Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma

This phase study was designed to evaluate the efficacy and safety of FOLFIRI as second-line treatment for metastatic esophageal carcinoma.

  • 7 views
  • 23 Jan, 2021
  • 1 location
Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer

Phase II study, randomized, open-label, multicentric, willing to establish the benefit of pursuing chemotherapy beyond 6 weeks for non progressive patients. The study will proceed in two successive phases : non randomized phase in which all patients will undergo chemotherapy second phase in which only non progressive patients are going …

metastasis
esophageal cancer
fluoropyrimidine
paclitaxel
cancer
  • 7 views
  • 22 Jan, 2021
  • 10 locations
Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer

This phase study was designed to evaluate the efficacy and safety of endostar combined with paclitaxel and nedaplatin as first-line therapy in treating patients with recurrent or metastatic esophageal squamous cell cancer.

metastasis
measurable disease
obstruction
jaundice
neutrophil count
  • 11 views
  • 23 Jan, 2021
  • 1 location
WaKING: Wnt and checKpoint INhibition in Gastric Cancer

This is a multicentre open-label non-randomised, Single Stage Ahern Design (with a 3+3 design for the safety run-in) phase II clinical trial of DKN-01 plus atezolizumab in patients with advanced unresectable or metastatic OGA who have progressed following chemotherapy.

metastasis
immunohistochemistry
liver metastasis
hepatitis b surface antigen
aptt
  • 0 views
  • 18 Mar, 2021
  • 1 location
A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer

The purpose of this study is to observe and evaluate the efficacy and safety of Camrelizumab combined with or without radiotherapy for the treatment of recurrent or metastatic esophageal cancer

esophageal cancer
esophagus cancer
neutrophil count
cancer
metastatic esophageal cancer
  • 0 views
  • 25 Jan, 2021
  • 1 location
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery

This phase I/II trial studies the side effects and best dose of olaparib when given together with ramucirumab and how well they work in treating patients with gastric or gastroesophageal junction cancer that has spread to other places in the body (metastatic), has come back (recurrent), or cannot be removed …

measurable disease
myocardial infarction
aptt
neutrophil count
oophorectomy
  • 83 views
  • 03 Feb, 2021
  • 25 locations
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

This phase II trial studies how well radiation therapy works for the treatment of gastrointestinal cancer that are spreading to other places in the body (metastatic). Radiation therapy uses high energy x-rays to kill cancer cells and shrink tumors. This trial is being done to determine if giving radiation therapy …

metastasis
neutrophil count
nausea
gastrointestinal cancer
  • 0 views
  • 24 Jan, 2021
  • 1 location
Induction Chemotherapy for Locally Advanced Esophageal Cancer

Evaluate mFOLFOX6 (5-Fluorouracil, Leucovorin and Oxaliplatin) chemotherapy as induction treatment prior to standard neoadjuvant chemoradiation to decrease the rate of distant recurrence among patients with locally advanced esophageal cancer.

leucovorin
oxaliplatin
squamous cell carcinoma
platelet count
adenocarcinoma
  • 8 views
  • 13 Mar, 2021
  • 1 location